86.6%
anti-CTLA4checkpoint inhibitorsmelanomaThe Cancer Genome AtlasGene Expression Omnibus
…ssociated with favorable outcomes only in patients treated with anti-CTLA4 (p<0.05). ScRNA analysis revealed elevated expression of NLRC5 …
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…ssociated with favorable outcomes only in patients treated with anti-CTLA4 (p<0.05). ScRNA analysis revealed elevated expression of NLRC5 …
…n immune checkpoint inhibitor (ICI) combination of anti-PD1 and anti-CTLA4. Treatment efficacy was evaluated by monitoring tumor growth, a…